本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viking Therapeutics, Inc.

29.95
-1.5800-5.01%
盤後30.240.2916+0.97%19:59 EDT
成交量:280.80萬
成交額:8,444.40萬
市值:34.94億
市盈率:-6.42
高:31.25
開:31.21
低:29.70
收:31.53
52周最高:43.15
52周最低:22.96
股本:1.17億
流通股本:1.10億
量比:1.45
換手率:2.55%
股息:- -
股息率:- -
每股收益(TTM):-4.6676
每股收益(LYR):-3.1920
淨資產收益率:-88.85%
總資產收益率:-51.86%
市淨率:8.56
市盈率(LYR):-9.38

資料載入中...

2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/26

重要事件披露

Form 8-K - Current report
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/02/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/23

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]